black box warning for semaglutide FDA adds intestinal blockage on Novo's Ozempic Black box warning - Wikipedia

Things like your BMI, existing health conditions, medications you take, and your age all affect whether you qualify

Factors that may influence perioperative management include: Medication characteristics : Daily GLP-1 medications (liraglutide, oral semaglutide) have shorter durations of action than weekly formulations (injectable semaglutide, dulaglutide, exenatide extended-release) [3] Risk factors : Higher doses, recent dose increases, active gastrointestinal symptoms, or known gastroparesis may increase risk [1] [3] Procedure type : More complex surgeries or those requiring general anaesthesia may warrant different approaches than minor procedures Individual patient factors : BMI, presence of diabetes, and other medical conditions Some anaesthetists may recommend temporarily pausing GLP-1 therapy before certain procedures, particularly for patients with additional risk factors

1 Recently, they were additionally approved for the treatment of obesity

Regular monitoring and open communication enable healthcare professionals to balance the benefits of weight loss against any adverse gastrointestinal effects

In Washington, our team works with your insurance to maximize coverage and connect you with savings programs and copay assistance